BCCIP anticorps (AA 181-233)
Aperçu rapide pour BCCIP anticorps (AA 181-233) (ABIN1886127)
Antigène
Voir toutes BCCIP AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 181-233
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Synthetic peptide contain a sequence corresponding to a region within amino acids 181 and 233 (Q9P287) of BCCIP
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- BCCIP (BRCA2 and CDKN1A Interacting Protein (BCCIP))
-
Sujet
-
This gene product was isolated on the basis of its interaction with BRCA2 and p21 proteins.It is an evolutionarily conserved nuclear protein with multiple interacting domains.The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium.Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21.This protein has also been implicated in the regulation of BRCA2 and RAD51 nuclear focus formation, double-strand break-induced homologous recombination, and cell cycle progression.Multiple transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq]
-
Poids moléculaire
- 36 kDa
-
ID gène
- 56647
-
NCBI Accession
- NM_016567, NP_057651
Antigène
-